SCHEMBL20150647

SCHEMBL20150647

C=CC[C@](C)(O)C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
MAPT P10636 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.41
TGM2 P21980 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19388495 1.00 ALDH1A1 (0.49) ALDH1A1MAPTHCAR2KMT2ASMN1; SMN2
SCHEMBL15114507 1.00 ALDH1A1 (0.49) ALDH1A1MAPTHCAR2KMT2ASMN1; SMN2
SCHEMBL29220153 0.86 ALDH1A1 (0.50) ALDH1A1HCAR2KMT2ASMN1; SMN2MEN1
SCHEMBL1273767 0.86 ALDH1A1 (0.50) ALDH1A1HCAR2KMT2ASMN1; SMN2MEN1
SCHEMBL28507066 0.84 ALDH1A1 (0.45) ALDH1A1HCAR2KMT2ASMN1; SMN2MAPK1
SCHEMBL14847458 0.84 ALDH1A1 (0.47) ALDH1A1HCAR2KMT2ASMN1; SMN2MEN1
SCHEMBL24425865 0.83 ALDH1A1 (0.49) ALDH1A1HCAR2KMT2AMAPK1L3MBTL1
SCHEMBL29815474 0.82 ALDH1A1 (0.46) ALDH1A1MAPTHCAR2KMT2ASMN1; SMN2
SCHEMBL4005645 0.82 ALDH1A1 (0.46) ALDH1A1HCAR2KMT2ASMN1; SMN2MEN1
SCHEMBL2032918 0.81 ALDH1A1 (0.55) ALDH1A1MAPTHCAR2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134724-A1 METHODS AND INTERMEDIATES FOR THE PREPARATION OF OMACETAXINE AND CEPHALOTAXINE DERIVATIVES THEREOF CURIA BUFFALO R&D, LLC 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134724-A1 METHODS AND INTERMEDIATES FOR THE PREPARATION OF OMACETAXINE AND CEPHALOTAXINE DERIVATIVES THEREOF MAOB, MAOA, NISCH ALDH1A1 418/4885MAPT 924/4885HCAR2 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.